4Ryu JH, Lee KH, Kim HD, et al. Follicular thyroid carcinoma with predominantly cystic formation presenting initially with multiple distant metastases[J].Joumal of Medical Ultrasonics, 2014,41 (2) : 233-237.
4Puig Retos en la gestion de la presacion farmaceutica. Fulls Economics 33 : 2-6,1999.
5Mossialos, E. Regulating expenditure on medicine in European Union countries. In Critical Challenges for Health Care Reform in Europe, ed. R. B.Saltman et al. WHO and Open University Press,Buckingham, England, 2000.
6Abel-Smith,B. ,and Mossialos, E. Cost containment and health care reform. A Study of the European Union. Health Policy 28(2) : 89-132,1994.
7Jacobzone, S. Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals. Labor Market and Social Policy-Occasional Papers No. 40. OECD, Paris, 2000.
8Saltman, R. B. , and Figures, J. European Health Care Reform: Analysis of Current Strategies.WHO, Copenhagen, 1997.
9Freeman,R. Policy Transfer in the Health Sector. A Framework for Analysis. Paper presented at the conference Beyond the Health Care State,European University Institute, Florence, February 26-27,1999.
10Visser, J. , and Hemmerijck, A. Learning and Mimicking: How European Welfare States, Cologne,October 6-8, 2000.
